Granulocytes Negatively Regulate Secretion of Transforming Growth Factor β1 by Bone Marrow Mononuclear Cells via Secretion of Erythropoietin Receptors in the Milieu

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Stem Cell Reviews and Reports

• Publication date

  2021-11-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12015-021-10292-xPMID 34775556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy

  2021cited by this paper
• Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy

  2020cited by this paper
• Erythropoietin and its derivatives: from tissue protection to immune regulation

  2020cited by this paper
• Transforming growth factor‐β boosts the functionality of human bone marrow‐derived mesenchymal stromal cells

  2020cited by this paper
• Erythropoietin receptor in B cells plays a role in bone remodeling in mice

  2020cited by this paper
• CD2 Immunobiology

  2020cited by this paper
• Identification and transcriptome analysis of erythroblastic island macrophages.

  2019cited by this paper
• TGF-β1 Negatively Regulates the Number and Function of Hematopoietic Stem Cells

  2018cited by this paper
• Megakaryocyte-derived excessive transforming growth factor β1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.

  2018cited by this paper
• Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

  2017cited by this paper
• Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules.

  2017cited by this paper
• Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.

  2016cited by this paper
• TGF-β signaling in the control of hematopoietic stem cells.

  2015cited by this paper
• Effects of erythropoietin on the bone microenvironment

  2012cited by this paper
• Lack of expression and function of erythropoietin receptors in the kidney.

  2012cited by this paper
• The effect of erythropoietin on normal and neoplastic cells

  2012cited by this paper
• Erythropoietin enhances immunostimulatory properties of immature dendritic cells

  2011cited by this paper
• Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages

  2011cited by this paper
• Erythropoietin receptor is detectable on peripheral blood lymphocytes and its expression increases in activated T lymphocytes

  2011cited by this paper
• Non-erythroid effects of erythropoietin

  2010cited by this paper
• Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment.

  2010cited by this paper
• Macrophages as novel target cells for erythropoietin

  2010cited by this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cited by this paper
• Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

  2006cited by this paper
• Differential Activation of MAPK Signaling Pathways by TGF-β1 Forms the Molecular Mechanism Behind Its Dose-Dependent Bidirectional Effects on Hematopoiesis

  2004cited by this paper
• Molecular Mechanisms Behind the Dose-Dependent Differential Activation of MAPK Pathways Induced by Transforming Growth Factor-β1 in Hematopoietic Cells

  2004cited by this paper
• Erythropoietin Receptor in Myelodysplastic Syndrome and Leukemia

  2002cited by this paper
• Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.

  2002cited by this paper
• Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies

  2000cited by this paper
• Systemic transforming growth factor‐beta in patients with bone marrow fibrosis—pathophysiological implications

  1998cited by this paper

• No citing papers are available for this paper.